BURRIS MICHELLE
Insider CIK 1229765 · ACER Director · HTGM Director · PZRX Director · KDNY Director · ADPT Director · OGXI CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2026-06-25 | 2026-06-29 | 52,084 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2026-06-25 | 2026-06-29 | 52,084 | $20.18 | $1.05M | 15,625 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2026-06-25 | 2026-06-29 | 52,084 | $7.80 | $406.3K | 67,709 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2026-03-11 | 2026-03-13 | 15,394 | $13.91 | $214.1K | 15,625 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2026-03-04 | 2026-03-06 | 15,625 | — | $0 | 31,019 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2026-03-03 | 2026-03-05 | 48,044 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2026-03-03 | 2026-03-05 | 48,044 | $3.99 | $191.7K | 63,438 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2026-03-03 | 2026-03-05 | 48,044 | $15.30 | $735.1K | 15,394 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2025-03-13 | 2025-03-17 | 36,291 | $7.19 | $260.9K | 15,394 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2025-03-06 | 2025-03-06 | 15,664 | $7.94 | $124.4K | 51,685 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2025-03-04 | 2025-03-06 | 23,726 | — | $0 | 23,726 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2025-03-04 | 2025-03-06 | 15,394 | — | $0 | 67,349 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2024-03-04 | 2024-03-06 | 48,044 | — | $0 | 48,044 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2024-03-04 | 2024-03-06 | 31,328 | — | $0 | 51,955 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 23,522 | $25.23 | $593.5K | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 5,948 | $23.19 | $137.9K | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 13,300 | $26.12 | $347.4K | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer | 2023-08-11 | 2023-08-11 | 3,300 | — | $0 | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise deriv | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 3,300 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2023-03-27 | 2023-03-29 | 2,341 | $8.49 | $19.9K | 20,627 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2023-03-14 | 2023-03-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2023-03-06 | 2023-03-08 | 23,329 | — | $0 | 23,329 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2023-03-06 | 2023-03-08 | 14,775 | — | $0 | 22,968 | SEC↗ |
| HTGM HTG MOLECULAR DIAGNOSTICS, | A Award deriv | 2022-09-15 | 2022-09-15 | 4,000 | — | $0 | 4,000 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2022-05-26 | 2022-05-31 | 13,300 | — | $0 | 13,300 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2022-05-26 | 2022-05-31 | 3,300 | — | $0 | 3,300 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2022-01-26 | 2022-01-28 | 16,722 | — | $0 | 16,722 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2022-01-26 | 2022-01-28 | 6,689 | — | $0 | 8,193 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2022-01-14 | 2022-01-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-08-27 | 2021-08-30 | 14,916 | — | $0 | 52,084 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-08-27 | 2021-08-30 | 14,916 | $35.00 | $522.1K | 1,504 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-08-27 | 2021-08-30 | 14,916 | $7.80 | $116.3K | 16,420 | SEC↗ |
| HTGM HTG MOLECULAR DIAGNOSTICS, | A Award deriv | 2021-08-18 | 2021-08-19 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-07-14 | 2021-07-19 | 2,500 | — | $0 | 67,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-07-14 | 2021-07-19 | 2,500 | $7.80 | $19.5K | 4,004 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-07-14 | 2021-07-19 | 2,500 | $36.80 | $92.0K | 1,504 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-06-17 | 2021-06-21 | 4,000 | — | $0 | 69,500 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-06-17 | 2021-06-21 | 4,000 | $7.80 | $31.2K | 5,504 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-06-17 | 2021-06-21 | 4,000 | $40.00 | $160.0K | 1,504 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-06-14 | 2021-06-16 | 2,500 | — | $0 | 73,500 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-06-14 | 2021-06-16 | 2,500 | $7.80 | $19.5K | 4,004 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-06-14 | 2021-06-16 | 2,500 | $38.56 | $96.4K | 1,504 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2021-06-04 | 2021-06-07 | 5,948 | — | $0 | 5,948 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-05-18 | 2021-05-19 | 2,500 | — | $0 | 76,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-05-18 | 2021-05-19 | 2,500 | $35.00 | $87.5K | 1,504 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-05-18 | 2021-05-19 | 2,500 | $7.80 | $19.5K | 4,004 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-04-14 | 2021-04-16 | 4,500 | — | $0 | 78,500 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-04-14 | 2021-04-16 | 4,500 | $43.41 | $195.3K | 1,504 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-04-14 | 2021-04-16 | 4,500 | $7.80 | $35.1K | 6,004 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-03-16 | 2021-03-17 | 1,500 | — | $0 | 83,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-03-16 | 2021-03-17 | 1,500 | $7.80 | $11.7K | 3,004 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-16 | 2021-03-17 | 1,500 | $47.00 | $70.5K | 1,504 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-03-15 | 2021-03-17 | 4,500 | — | $0 | 84,500 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-03-15 | 2021-03-17 | 4,500 | $7.80 | $35.1K | 6,004 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-15 | 2021-03-17 | 891 | $41.17 | $36.7K | 5,113 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-15 | 2021-03-17 | 3,609 | $41.89 | $151.2K | 1,504 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-02-16 | 2021-02-16 | 6,000 | — | $0 | 89,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-02-16 | 2021-02-16 | 6,000 | $65.08 | $390.5K | 1,504 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-02-16 | 2021-02-16 | 6,000 | $7.80 | $46.8K | 7,504 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2021-02-14 | 2021-02-16 | 3,759 | — | $0 | 3,759 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2021-02-14 | 2021-02-16 | 1,504 | — | $0 | 1,504 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-01-14 | 2021-01-15 | 6,000 | — | $0 | 95,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-01-14 | 2021-01-15 | 6,000 | $7.80 | $46.8K | 6,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-01-14 | 2021-01-15 | 5,041 | $65.77 | $331.5K | 959 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-01-14 | 2021-01-15 | 959 | $66.43 | $63.7K | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2020-12-14 | 2020-12-16 | 6,000 | — | $0 | 101,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-12-14 | 2020-12-16 | 1,651 | $59.44 | $98.1K | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-12-14 | 2020-12-16 | 3,367 | $58.96 | $198.5K | 1,651 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2020-12-14 | 2020-12-16 | 6,000 | $7.80 | $46.8K | 6,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-12-14 | 2020-12-16 | 982 | $57.42 | $56.4K | 5,018 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2020-11-16 | 2020-11-18 | 6,000 | — | $0 | 107,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-11-16 | 2020-11-18 | 5,021 | $47.57 | $238.8K | 979 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2020-11-16 | 2020-11-18 | 6,000 | $7.80 | $46.8K | 6,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-11-16 | 2020-11-18 | 979 | $48.30 | $47.3K | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2020-10-14 | 2020-10-16 | 12,000 | — | $0 | 113,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-10-14 | 2020-10-16 | 7,351 | $53.07 | $390.1K | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2020-10-14 | 2020-10-16 | 12,000 | $7.80 | $93.6K | 12,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-10-14 | 2020-10-16 | 4,649 | $52.48 | $244.0K | 7,351 | SEC↗ |
| KDNY ADURO BIOTECH, INC. | A Award deriv | 2020-10-06 | 2020-10-07 | 23,522 | — | $0 | 23,522 | SEC↗ |
| HTGM HTG MOLECULAR DIAGNOSTICS, | A Award deriv | 2020-08-19 | 2020-08-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2020-02-13 | 2020-02-18 | 8,888 | — | $0 | 8,888 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 9,000 | — | $0 | 9,000 | SEC↗ |
| HTGM HTG MOLECULAR DIAGNOSTICS, | A Award deriv | 2019-08-14 | 2019-08-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HTGM HTG MOLECULAR DIAGNOSTICS, | A Award | 2019-08-14 | 2019-08-16 | 2,500 | — | $0 | 2,500 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2019-02-01 | 2019-02-05 | 6,000 | — | $0 | 6,000 | SEC↗ |
| HTGM HTG MOLECULAR DIAGNOSTICS, | A Award deriv | 2018-08-15 | 2018-08-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2017-10-04 | 2017-10-06 | 9,000 | — | $0 | 9,000 | SEC↗ |
| PZRX PHASERX, INC. | A Award deriv | 2017-05-25 | 2017-05-30 | 14,000 | — | $0 | 14,000 | SEC↗ |
| PZRX PHASERX, INC. | A Award deriv | 2016-06-01 | 2016-06-03 | 13,631 | — | $0 | 13,631 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-08 | 2012-05-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-08 | 2012-05-10 | 7,500 | — | $0 | 7,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-08 | 2012-05-10 | 15,000 | — | $0 | 15,000 | SEC↗ |